Research Paper Volume 14, Issue 19 pp 7866—7876
Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma
Figure 3. Clinical significance of DTYMK in lung adenocarcinoma. Correlation between DTYMK expression and clinical parameters, including (A) pathological stage, (B–D) TNM stage NS: P >0.05, ***P < 0.001.